Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Amortization of Deferred Charges (2017 - 2018)

Historic Amortization of Deferred Charges for Cogent Biosciences (COGT) over the last 2 years, with Q4 2018 value amounting to $7000.0.

  • Cogent Biosciences' Amortization of Deferred Charges rose 1666.67% to $7000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $23000.0, marking a year-over-year increase of 1500.0%. This contributed to the annual value of $23000.0 for FY2018, which is 1500.0% up from last year.
  • Cogent Biosciences' Amortization of Deferred Charges amounted to $7000.0 in Q4 2018, which was up 1666.67% from $5000.0 recorded in Q3 2018.
  • Cogent Biosciences' Amortization of Deferred Charges' 5-year high stood at $7000.0 during Q4 2018, with a 5-year trough of $4000.0 in Q1 2017.